Jan 15 • 15:14 UTC 🇪🇸 Spain El País

A generic Ozempic for 15 euros per month or how to revolutionize the obesity drug market

The expiration of Novo Nordisk's patent in some countries pressures the Danish pharmaceutical company as its diabetes injection Ozempic becomes synonymous with weight loss globally.

📡 Similar Coverage